{"id":7056,"date":"2011-03-22T12:53:53","date_gmt":"2011-03-22T16:53:53","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=7056"},"modified":"2011-07-19T17:44:30","modified_gmt":"2011-07-19T21:44:30","slug":"aha-releases-new-recommendations-for-management-of-acute-vte","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2011\/03\/22\/aha-releases-new-recommendations-for-management-of-acute-vte\/","title":{"rendered":"AHA Releases New Recommendations for Management of Acute VTE"},"content":{"rendered":"<p>The AHA is offering new guidance for the management of patients with  pulmonary embolism, iliofemoral deep vein   thrombosis, and   chronic  thromboembolic pulmonary  hypertension. The <a href=\"http:\/\/circ.ahajournals.org\/cgi\/reprint\/CIR.0b013e318214914fv1\">scientific   statement is published online in <\/a><em><a href=\"http:\/\/circ.ahajournals.org\/cgi\/reprint\/CIR.0b013e318214914fv1\">Circulation.<\/a><\/em> In addition to advice about anticoagulant therapy, the statement offers   extensive recommendations about the appropriate use of fibrinolytic  agents,  catheter-based and surgical interventions, and IVC filters.<\/p>\n<p>\u201cIt is important for doctors to be able to identify the severity of     these disorders and to select who might be eligible for more invasive     therapies, such as clot-busting drugs, catheter-based treatments or     surgery,\u201d said M. Sean McMurtry, co-chair of the    writing group, in  <a href=\"http:\/\/www.newsroom.heart.org\/index.php?s=43&amp;item=1293\">an AHA press release<\/a>. \u201cVenous thromboembolism is very common, and  frequently a    complication of other ailments. While most patients need  blood  thinners   only, patients with more severe forms of venous   thromboembolism may   benefit from more aggressive treatments.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The AHA is offering new guidance for the management of patients with pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension. The scientific statement is published online in Circulation. In addition to advice about anticoagulant therapy, the statement offers extensive recommendations about the appropriate use of fibrinolytic agents, catheter-based and surgical interventions, and [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[495,1,16],"tags":[367,596,747,748],"class_list":["post-7056","post","type-post","status-publish","format-standard","hentry","category-anticoagulation-2","category-general","category-vascular","tag-dvt","tag-pulmonary-embolism","tag-venous-thromboembolism","tag-vte"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/7056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=7056"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/7056\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=7056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=7056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=7056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}